Cargando…
Chimeric Antigen Receptor-T Cells: A Pharmaceutical Scope
Cancer is among the leading causes of death worldwide. Therefore, improving cancer therapeutic strategies using novel alternatives is a top priority on the contemporary scientific agenda. An example of such strategies is immunotherapy, which is based on teaching the immune system to recognize, attac...
Autores principales: | Hernández-López, Alejandrina, Téllez-González, Mario A., Mondragón-Terán, Paul, Meneses-Acosta, Angélica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417740/ https://www.ncbi.nlm.nih.gov/pubmed/34489708 http://dx.doi.org/10.3389/fphar.2021.720692 |
Ejemplares similares
-
Chimeric antigen receptor T-cell therapy
por: Burge, Cale, et al.
Publicado: (2023) -
Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma
por: Guo, Xingliang, et al.
Publicado: (2018) -
BAY 60-6583 Enhances the Antitumor Function of Chimeric Antigen Receptor-Modified T Cells Independent of the Adenosine A2b Receptor
por: Tang, Jiaxing, et al.
Publicado: (2021) -
The inducible caspase-9 suicide gene system as a “safety switch” to limit on-target, off-tumor toxicities of chimeric antigen receptor T cells
por: Gargett, Tessa, et al.
Publicado: (2014) -
Chimeric Antigen Receptor T-cell Therapy in Hematologic Malignancies and Patient-reported Outcomes: A Scoping Review
por: Efficace, Fabio, et al.
Publicado: (2022)